These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2204 related articles for article (PubMed ID: 15580322)

  • 1. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".
    Rupp H; Rupp TP; Wagner D; Alter P; Maisch B
    Herz; 2006 Dec; 31 Suppl 3():30-49. PubMed ID: 17575804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
    Rupp H
    Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease prevention and treatment.
    von Schacky C
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):193-8. PubMed ID: 19520557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
    Holub BJ
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study.
    Streppel MT; Ocké MC; Boshuizen HC; Kok FJ; Kromhout D
    Eur Heart J; 2008 Aug; 29(16):2024-30. PubMed ID: 18641046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?
    Donadio JV; Bergstralh EJ; Bibus DM; Grande JP
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):933-9. PubMed ID: 17699310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.
    Hogg RJ; Fitzgibbons L; Atkins C; Nardelli N; Bay RC;
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1167-72. PubMed ID: 17699343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
    Pauwels EK; Kostkiewicz M
    Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.
    Arachchige PG; Takahashi Y; Ide T
    Metabolism; 2006 Mar; 55(3):381-90. PubMed ID: 16483883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantification of total eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid in plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Salm P; Taylor PJ; Kostner K
    Biomed Chromatogr; 2011 Jun; 25(6):652-9. PubMed ID: 20737653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids and cardiovascular disease.
    von Schacky C
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):129-35. PubMed ID: 17284999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease.
    Sijben JW; Calder PC
    Proc Nutr Soc; 2007 May; 66(2):237-59. PubMed ID: 17466105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men.
    Yusof HM; Miles EA; Calder P
    Prostaglandins Leukot Essent Fatty Acids; 2008 Mar; 78(3):219-28. PubMed ID: 18403189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters.
    Bryhn M; Hansteen H; Schanche T; Aakre SE
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jul; 75(1):19-24. PubMed ID: 16806871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Omega-3 fatty acids in cardiology. Latest developments].
    von Schacky C
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():97-101. PubMed ID: 17955786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
    Berstad P; Seljeflot I; Veierød MB; Hjerkinn EM; Arnesen H; Pedersen JI
    Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
    Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
    Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 111.